Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze DGX stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate DGX investment potential.

What is DGX stock price today?

Get real-time DGX stock price, historical data, and price charts on Financhill. Track DGX performance with our advanced analysis tools.

Is DGX a good investment?

Evaluate DGX investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy DGX stock?

To buy DGX stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of DGX?

View detailed market capitalization data and company valuation metrics for DGX on our comprehensive analysis page.

What is the P/E ratio of DGX?

Use our fundamental analysis tools to view DGX P/E ratio and compare valuation metrics with industry peers.

What are DGX earnings?

View DGX earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Quest Diagnostics, Inc. 10K Form

Buy

DGX
Quest Diagnostics, Inc.

Last Price:

$202.35

Seasonality Move:

9.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-24	10Q	DGX/Quest Diagnostics, Inc. Quarterly
2024-02-22	10K	DGX/Quest Diagnostics, Inc. Annual
2023-10-25	10Q	DGX/Quest Diagnostics, Inc. Quarterly
2023-07-27	10Q	DGX/Quest Diagnostics, Inc. Quarterly
2023-04-28	10Q	DGX/Quest Diagnostics, Inc. Quarterly
2023-02-21	10K	DGX/Quest Diagnostics, Inc. Annual

Receive DGX News And Ratings

See the #1 stock for the next 7 days that we like better than DGX

DGX Financial Statistics

Sales & Book Value

Annual Sales:	$11B
Cash Flow:	$307M
Price / Cash Flow:	16.79
Annual Sales:	$65.18
Price / Book:	3.11

Profitability

EPS (TTM):	8.75510
Net Income (TTM):	$1B
Gross Margin:	$3.5B
Return on Equity:	14.49%
Return on Assets:	6.49%

Quest Diagnostics, Inc. Earnings Forecast

Key Quest Diagnostics, Inc. Financial Ratios

The Gross Profit Margin over the past 30 years for DGX is 31.93%.
The Selling, General & Administrative Expenses for DGX have been equal to 17.83% of Gross Profit Margin.
The Research & Development expenses have been 0.00% of Revenue.
The Interest Expense is 25.34% of Operating Income.
The Net Earning history of DGX is 9.44% of Total Revenues.
Per Share Earnings over the last 30 years have been positive in 20 years.

Quest Diagnostics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	S&P500
Industry:	Health Care Providers & Services
Sector:	Health Care
Current Symbol:	DGX
CUSIP:	74834L
Website:	questdiagnostics.com

Debt

Debt-to-Equity Ratio:	0.89
Current Ratio:	1.04
Quick Ratio:	0.8

Price-to-Earnings

Trailing P/E Ratio:	23.13
Forward P/E Ratio:	17.63

DGX Technical Analysis vs Fundamental Analysis

Buy

Quest Diagnostics, Inc. (DGX) is a Buy

Is Quest Diagnostics, Inc. a Buy or a Sell?

Quest Diagnostics, Inc. stock is rated a Buy

The current Quest Diagnostics, Inc. [DGX] share price is $202.41. The Score for DGX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.